Drug reference
indacaterol-glycopyrronium
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Respiratory (Combination(Respiratory))
Mechanism of action
Glycopyrronium: Long-acting muscarinic antagonist (LAMA); often referred to as an anticholinergic; produces bronchodilation by inhibiting acetylcholine’s effect on muscarinic receptors in the airway smooth muscle. Indacaterol: Long-acting beta2-agonist (LABA), cause relaxation of bronchial smooth muscle.
Common side effects
- Nasopharyngitis
- Back pain
- Oropharyngeal pain
- Rare: Hypertension
Contraindications
- Hypersensitivity All LABAs are contraindicated in patients with asthma without use of an inhaled corticosteroid; indacaterol/glycopyrrolate is not indicated for the treatment of asthma
Related conditions
Frequently asked questions
What drug class is indacaterol-glycopyrronium?
indacaterol-glycopyrronium belongs to: Respiratory.
How does indacaterol-glycopyrronium work?
Glycopyrronium: Long-acting muscarinic antagonist (LAMA); often referred to as an anticholinergic; produces bronchodilation by inhibiting acetylcholine’s effect on muscarinic receptors in the airway smooth muscle. Indacaterol: Long-acting beta2-agonist (LABA), cause relaxation of bronchial smooth muscle.
What are the common side effects of indacaterol-glycopyrronium?
Nasopharyngitis, Back pain, Oropharyngeal pain, Rare: Hypertension
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.